This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Fred Y. Aoki, MD; Daniel S. Sitar, PhD
Winnipeg, Manitoba, Canada

Arch Intern Med. 1987;147(6):1189.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Atkinson et al,¹ in a previous issue of the ARCHIVES, made the interesting observation that 48% of 78 mentally handicapped children and adults experienced apparent side effects while ingesting amantadine hydrochloride for influenza A prophylaxis and commented that serum amantadine concentrations were two to three times higher than expected. Serum amantadine concentrations, six to eight hours after the last dose, on day 28 of drug ingestion, averaged 1991 and 1358 ng/mL in eight and six patients, respectively. No clear explanation for these observations was evident; the patients were 5 to 64 years of age, had normal serum creatinine concentrations, and were ingesting 6.6 mg/kg/d of the drug, within the manufacturer's recommended dose range. To determine whether pharmacokinetic factors might account in part for their observation, we reexamined unpublished data from our study of amantadine plasma concentrations (Cp) in 15 young adults ingesting 50, 200, or 300 . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?